中文版正在生成中，先为你展示英文版分析。
AI核心结论
GL (Globe Life) delivered solid FY2025 results with revenue growing 3.7% to $6.0B and net income rising 8.4% to $1.16B, while EPS surged 19.0% to $14.27 driven by share buybacks and improved profitability.
营业收入
$5.99B
同比 ++3.74%
每股收益（基本）
$14.27
同比 ++19.02%
提交于 · 解读更新于 · 来源: SEC EDGAR 10-K 原文
Globe Life (GL) FY2025 营收 $5.99B，同比增长 3.7%。 净利润 $1.16B，同比增长 8.4%，稀释每股收益 $14.07。
GL achieved revenue of $5.99B in FY2025, up 3.7% from $5.78B in the prior year, reflecting steady growth in its life and health insurance segments. This consistent top-line expansion underscores the company's ability to grow its policyholder base and premium income.
来源: Source: 10-K Financial Data (Income Statement)
Net income grew 8.4% year-over-year to $1.16B, outpacing revenue growth and resulting in a net margin of 19.4%, up from approximately 18.5% in the prior year. This margin improvement suggests better claims management or favorable underwriting results.
来源: Source: 10-K Financial Data (Income Statement, Key Ratios)
Basic EPS jumped 19.0% to $14.27 and diluted EPS rose 17.8% to $14.07, significantly outpacing net income growth of 8.4%. This acceleration reflects the impact of $881M in share buybacks during FY2025, which reduced the share count and boosted per-share earnings.
来源: Source: 10-K Financial Data (Income Statement, Cash Flow)
GL returned approximately $967M to shareholders in FY2025 through $881M in share repurchases and $86M in dividends. While buybacks declined 12.1% from the prior year's $1.0B, the program remains a significant driver of shareholder value.
来源: Source: 10-K Financial Data (Cash Flow Statement)
Stockholders' equity increased 12.6% to $5.97B, while long-term debt remained essentially flat at $2.32B, indicating disciplined liability management. Total assets grew 6.0% to $30.8B, consistent with an expanding insurance investment portfolio.
来源: Source: 10-K Financial Data (Balance Sheet)
GL carries a debt-to-equity ratio of 4.16, which is elevated and reflects the capital-intensive nature of insurance operations. While long-term debt is stable at $2.32B, the high leverage ratio limits financial flexibility and increases sensitivity to interest rate changes or credit market disruptions.
来源: Source: 10-K Financial Data (Key Ratios, Balance Sheet)
Operating cash flow dipped slightly by 0.4% to $1.40B in FY2025, even as net income grew 8.4%. This divergence between earnings and cash generation warrants monitoring, as sustained pressure on cash flow could constrain future capital returns or investment capacity.
来源: Source: 10-K Financial Data (Cash Flow Statement)
As a life and health insurance company, GL's financial results are highly sensitive to mortality rates, morbidity trends, and policyholder behavior. Adverse changes in claims experience — such as elevated death rates or increased health claims — could materially impact underwriting profitability.
来源: Source: 10-K Financial Data (Income Statement)
GL reduced share repurchases by 12.1% to $881M in FY2025, down from $1.0B in the prior year. If operating cash flow remains flat or declines, the company may face pressure to further reduce buybacks, which could slow EPS growth momentum that has been a key driver of shareholder returns.
来源: Source: 10-K Financial Data (Cash Flow Statement)
With total assets of $30.8B, the majority of which are likely fixed-income investments typical of insurance companies, GL is exposed to interest rate risk. Rising or falling rates can affect both the market value of the investment portfolio and the reinvestment yields on maturing securities.
来源: Source: 10-K Financial Data (Balance Sheet)
FY2025 实际 EPS $3.39，分析师一致预期 $3.54，不及预期 -4.2%。
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业收入 | $5.99B | $5.78B | +3.74% |
净利润 | $1.16B | $1.07B | +8.45% |
每股收益（基本） | $14.27 | $11.99 | +19.02% |
每股收益（稀释） | $14.07 | $11.94 | +17.84% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
总资产 | $30.81B | $29.08B | +5.98% |
总负债 | $24.84B | $23.77B | +4.49% |
股东权益 | $5.97B | $5.31B | +12.61% |
长期债务 | $2.32B | $2.32B | -0.15% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
经营活动现金流 | $1.4B | $1.4B | -0.43% |
投资活动现金流 | $-643.62M | $-641.52M | -0.33% |
筹资活动现金流 | $-768.05M | $-715.84M | -7.29% |
股息支出 | $86.07M | $85.48M | +0.68% |
股票回购 | $880.98M | $1B | -12.09% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
净利率 | 19.4% | — | — |
净资产收益率 | 19.4% | — | — |
总资产收益率 | 3.8% | — | — |
资产负债率 | $4.157 | — | — |
Life & Health Insurance 行业其他公司
GL delivered strong FY2025 results with revenue of $5.99B (+3.7%) and net income of $1.16B (+8.4%). Basic EPS surged 19.0% to $14.27, significantly boosted by $881M in share repurchases that reduced the outstanding share count.
GL's basic EPS grew 19.0% to $14.27 in FY2025, far outpacing net income growth of 8.4%. The key driver was the company's aggressive share buyback program, which repurchased $881M worth of shares, meaningfully reducing the share count and amplifying per-share earnings.
GL returned approximately $967M to shareholders in FY2025, comprising $881M in share repurchases (down 12.1% from $1.0B in the prior year) and $86M in dividends. The buyback program remains the primary vehicle for capital return.
GL's balance sheet shows total assets of $30.8B and stockholders' equity of $5.97B (+12.6%), with long-term debt stable at $2.32B. The main concern is a high debt-to-equity ratio of 4.16, though operating cash flow of $1.40B provides solid coverage for debt service and capital returns.
Yes, GL's profitability improved in FY2025 with net margin expanding to 19.4% from approximately 18.5% in the prior year, and ROE reaching 19.4%. Net income grew 8.4% to $1.16B, outpacing the 3.7% revenue growth, indicating improved underwriting or investment income efficiency.